Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Enrolling by invitation 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1Breast 1

Conditions

Uterine Cervical Neoplasms 1Treatment Adherence and Compliance 1Orgasm 1Depression 1Anxiety Disorders 1

Interventions

Paclitaxel 575Carboplatin 521Cisplatin 351Bevacizumab 252pembrolizumab 228Gemcitabine 157Topotecan 128Cyclophosphamide 128liposomal doxorubicin 127olaparib 120Taxes 113Radiotherapy 110Docetaxel 94Brachytherapy 89Doxorubicin 84Drug Therapy 81niraparib 75Nivolumab 71Magnetic Resonance Spectroscopy 71Specimen Handling 65fludarabine 57Biopsy 55Hyperthermic Intraperitoneal Chemotherapy 53Filgrastim 52Letrozole 50Oxaliplatin 48durvalumab 47Immunoglobulin G 47atezolizumab 46Platinum 44

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Cognitive Restructuring × Gynecologic × Clear all
NCT04165460 2025-05-28

Effect of Two Cognitive-Behavioral Interventions on Cervical Cancer Patients

National Institute of Cancerología

Phase NA Enrolling by invitation
92 enrolled
Gynecologic

Treatment Adherence and Compliance, Anxiety Disorders, Uterine Cervical Neoplasms, Depression, Orgasm

Data powered by HemOnc (CC BY 4.0) Colophon ⚡